首页> 美国卫生研究院文献>other >Arguments to Apply Epinephrine for Pocket Hematoma Reduction. The MAITRE Study
【2h】

Arguments to Apply Epinephrine for Pocket Hematoma Reduction. The MAITRE Study

机译:将肾上腺素用于减少口袋血肿的观点。 MAITRE研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pocket hematoma (PH) is a common complication of implantations of cardiac electrophysiological devices with occurring at a particularly high rate in patients on oral anticoagulation or antiplatelet treatment. Different pharmacological agents with hemostatic effect are used to avoid PH. We supposed that the vasoconstrictor effects of epinephrine may reduce bleeding extent and be effective in prevention of PH. Maitre is the first clinical trial conducted with an aim to show the safety and efficacy of epinephrine in PH prophylaxis. We randomized 133 patients to receive either epinephrine or saline solution, which were added to a local anesthetic administered during pacemaker implantation. In cases of diffuse bleeding a method of pocket drainage was effectively used. Results showed that risk of PH was significantly higher in the group receiving epinephrine. We conclude that a local epinephrine effect may lead to a false impression of adequate hemostasis and force a surgeon to refuse from drainage insertion.
机译:口袋血肿(PH)是心脏电生理设备植入的常见并发症,在接受口服抗凝或抗血小板治疗的患者中发生率特别高。使用具有止血作用的不同药物来避免PH。我们认为肾上腺素的血管收缩作用可能会减少出血程度并有效预防PH。 Maitre是进行的第一项临床试验,旨在证明肾上腺素在预防PH中的安全性和有效性。我们将133例患者随机分为接受肾上腺素或盐溶液的患者,在起搏器植入过程中将其加入局部麻醉剂中。在弥漫性出血的情况下,有效地采用了口袋引流的方法。结果表明,接受肾上腺素治疗组的PH风险明显更高。我们得出的结论是,局部肾上腺素作用可能导致适当止血的假象,并迫使外科医生拒绝引流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号